Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 4.66% is 135% above its 5-year average of -13.19%, near the high end of its 5-year range (-49.20%–15.57%).
30.28% above its 12-month average of 3.58%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.43%.
NET PROFIT MARGIN
4.66%
NET PROFIT MARGIN AVG TTM
3.58%
NET PROFIT MARGIN AVG 3Y
-11.83%
NET PROFIT MARGIN AVG 5Y
-13.19%
NET PROFIT MARGIN AVG 10Y
-12.35%
NET PROFIT MARGIN AVG 15Y
-11.24%
NET PROFIT MARGIN AVG 20Y
-13.34%
CURRENT VS TTM AVG
+30.28%
CURRENT VS 3Y AVG
+139.39%
CURRENT VS 5Y AVG
+135.34%
CURRENT VS 10Y AVG
+137.72%
CURRENT VS 15Y AVG
+141.44%
CURRENT VS 20Y AVG
+134.94%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 735 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
OptimizeRx Corp.
Market Cap
$165.79M
Net Profit Margin
4.66%
TTM Avg
3.58%
3Y Avg
-11.83%
5Y Avg
-13.19%
Market Cap
$164.16M
Net Profit Margin
-80.29%
TTM Avg
-52.87%
3Y Avg
-55.88%
5Y Avg
-51.71%
Market Cap
$163.00M
Net Profit Margin
-257.10%
TTM Avg
-196.56%
3Y Avg
-155.96%
5Y Avg
-114.00%
Market Cap
$169.85M
Net Profit Margin
-19.76%
TTM Avg
3.38%
3Y Avg
2.83%
5Y Avg
6.10%
Market Cap
$170.85M
Net Profit Margin
-170.10%
TTM Avg
-145.13%
3Y Avg
-100.04%
5Y Avg
-83.24%
Market Cap
$159.33M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.79%
Market Cap
$157.57M
Net Profit Margin
-6.94%
TTM Avg
-8.61%
3Y Avg
-17.97%
5Y Avg
-12.59%
Market Cap
$173.23M
Net Profit Margin
-229.20%
TTM Avg
-206.03%
3Y Avg
-659.07%
5Y Avg
-1951.89%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $165.79M | 4.66% | 3.58% | -11.83% | -13.19% |
| Quanterix Corporation (QTRX)vs › | $164.16M | -80.29% | -52.87% | -55.88% | -51.71% |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -257.10% | -196.56% | -155.96% | -114.00% |
| PepGen Inc. (PEPG)vs › | $162.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | -19.76% | 3.38% | 2.83% | 6.10% |
| MediWound Ltd. (MDWD)vs › | $170.85M | -170.10% | -145.13% | -100.04% | -83.24% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.33M | 0.00% | 0.00% | 0.00% | 0.79% |
| Inogen, Inc. (INGN)vs › | $157.57M | -6.94% | -8.61% | -17.97% | -12.59% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -229.20% | -206.03% | -659.07% | -1951.89% |
| Nkarta, Inc. (NKTX)vs › | $172.78M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
11.4%
Net Profit Margin
4.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -3.43% |
| 2026-03-31 | -2.49% |
| 2025-12-31 | 15.57% |
| 2025-09-30 | 2.99% |
| 2025-06-30 | 5.25% |
| 2025-03-31 | -10.03% |
| 2024-12-31 | -0.24% |
| 2024-09-30 | -42.82% |
| 2024-06-30 | -21.31% |
| 2024-03-31 | -35.04% |
| 2023-12-31 | -14.60% |
| 2023-09-30 | -17.54% |
| 2023-06-30 | -30.11% |
| 2023-03-31 | -49.20% |
| 2022-12-31 | -1.66% |
| 2022-09-30 | -22.98% |
| 2022-06-30 | -27.79% |
| 2022-03-31 | -27.39% |
| 2021-12-31 | 3.07% |
| 2021-09-30 | 0.25% |
| 2021-06-30 | 2.58% |
| 2021-03-31 | -5.68% |
| 2020-12-31 | 8.26% |
| 2020-09-30 | -2.69% |
| 2020-06-30 | -12.27% |
| 2020-03-31 | -29.06% |
| 2019-12-31 | -26.89% |
| 2019-09-30 | -31.40% |
| 2019-06-30 | 5.80% |
| 2019-03-31 | 0.13% |
| 2018-12-31 | -1.67% |
| 2018-09-30 | 4.52% |
| 2018-06-30 | 5.50% |
| 2018-03-31 | -4.60% |
| 2017-12-31 | -5.92% |
| 2017-09-30 | -20.07% |
| 2017-06-30 | -12.61% |
| 2017-03-31 | -41.02% |
| 2016-12-31 | -15.39% |
| 2016-09-30 | -13.58% |
| 2016-06-30 | -30.94% |
| 2016-03-31 | -20.00% |
| 2015-12-31 | -20.52% |
| 2015-09-30 | 4.38% |
| 2015-06-30 | -9.22% |
| 2015-03-31 | -7.48% |
| 2014-12-31 | 3.55% |
| 2014-09-30 | -24.34% |
| 2014-06-30 | -3.62% |
| 2014-03-31 | -49.59% |
| 2013-12-31 | -2.44% |
| 2013-09-30 | 0.78% |
| 2013-06-30 | 32.08% |
| 2013-03-31 | -15.66% |
| 2012-12-31 | 15.85% |
| 2012-09-30 | -23.43% |
| 2012-06-30 | -14.76% |
| 2012-03-31 | -91.30% |
| 2011-12-31 | -154.57% |
| 2011-09-30 | -505.96% |
| 2011-06-30 | -216.15% |
| 2011-03-31 | -54.57% |
| 2010-12-31 | -2975.74% |
| 2010-09-30 | -1240.48% |
| 2010-06-30 | -5232.67% |
| 2010-03-31 | -20340.37% |
| 2009-12-31 | -15439.64% |
| 2009-09-30 | -7559.45% |
| 2009-06-30 | -9920.12% |
| 2009-03-31 | -107059.24% |
| 2008-12-31 | -21770.41% |
| 2008-09-30 | -14528.17% |
| 2008-06-30 | -3209.05% |
| 2008-03-31 | -1085.53% |
